Allegion (NYSE:ALLE – Get Free Report) had its price objective hoisted by research analysts at Barclays from $117.00 to $135.00 in a report issued on Wednesday, Benzinga reports. The firm presently has an “underweight” rating on the scientific and technical instruments company’s stock. Barclays‘s price target indicates a potential downside of 7.46% from the company’s previous close.
A number of other brokerages have also weighed in on ALLE. Wells Fargo & Company lifted their price objective on Allegion from $125.00 to $137.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. StockNews.com upgraded shares of Allegion from a “hold” rating to a “buy” rating in a report on Saturday, July 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Allegion has a consensus rating of “Hold” and an average price target of $129.00.
View Our Latest Stock Analysis on ALLE
Allegion Stock Up 0.0 %
Allegion (NYSE:ALLE – Get Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The scientific and technical instruments company reported $1.96 EPS for the quarter, beating the consensus estimate of $1.84 by $0.12. The firm had revenue of $965.60 million during the quarter, compared to the consensus estimate of $953.63 million. Allegion had a net margin of 15.08% and a return on equity of 47.21%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.76 earnings per share. On average, equities research analysts expect that Allegion will post 7.26 earnings per share for the current year.
Institutional Investors Weigh In On Allegion
A number of hedge funds and other institutional investors have recently bought and sold shares of ALLE. Norden Group LLC purchased a new stake in shares of Allegion in the first quarter worth $2,271,000. BNP Paribas Financial Markets raised its holdings in Allegion by 90.7% in the first quarter. BNP Paribas Financial Markets now owns 121,597 shares of the scientific and technical instruments company’s stock worth $16,380,000 after buying an additional 57,832 shares during the last quarter. Morningstar Investment Services LLC lifted its stake in shares of Allegion by 107.6% in the fourth quarter. Morningstar Investment Services LLC now owns 218,489 shares of the scientific and technical instruments company’s stock worth $27,717,000 after buying an additional 113,227 shares in the last quarter. Oppenheimer & Co. Inc. grew its holdings in shares of Allegion by 18.3% during the fourth quarter. Oppenheimer & Co. Inc. now owns 66,701 shares of the scientific and technical instruments company’s stock valued at $8,450,000 after buying an additional 10,300 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its holdings in shares of Allegion by 5.3% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 215,829 shares of the scientific and technical instruments company’s stock valued at $29,074,000 after buying an additional 10,896 shares during the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.
About Allegion
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.
See Also
- Five stocks we like better than Allegion
- What is the Hang Seng index?
- When Is the Best Time to Invest in Mutual Funds?
- Investing in the High PE Growth Stocks
- Is NVIDIA Stock in a Correction or Consolidation?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Allegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegion and related companies with MarketBeat.com's FREE daily email newsletter.